Vienna, Austria - One of the largest studies to date looking at the impact of stent thrombosis and its treatment suggests that once thrombosis occurs, it matters very little whether the culprit was a ...

Intraprocedural stent thrombosis is a relatively rare complication of percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS), occurring less than 1% of of the time, ...

Please provide your email address to receive an email when new articles are posted on . Since the beginning of stent use, patients have received a “stent card” after PCI with information about their ...

In a large, real-world population of STEMI patients, early stent thrombosis is equally rare regardless of whether bivalirudin, heparin, or a glycoprotein IIb/IIIa inhibitor (GPI) is used during ...

Please provide your email address to receive an email when new articles are posted on . PCI for in-stent chronic total occlusion had similar success rates and in-hospital complications compared with ...

In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved long-term survival and fewer cardiac arrests at one year. The ...

(PARIS, FRANCE) - Stent thrombosis following urgent angioplasty for acute heart attack occurred in less than 1% of patients in a large, "real-world" registry, regardless of whether the antithrombotic ...

A study, published in The New England Journal of Medicine, compared drug-eluting bioresorbable vascular scaffolds with drug-eluting metallic stents in percutaneous coronary interventions. Abbott ...

In patients with three-vessel and/or left main coronary artery disease (CAD), percutaneous coronary intervention (PCI) with paclitaxel-eluting stents is equivalent to coronary artery bypass grafting ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window For percutaneous ...

Demand for coronary stents is currently witnessing robust growth in India, mainly due to FDA approval for new stents and increasing number of PCI procedures in hospitals. The coronary stents market in ...